North America Organ Preservation Market (2025-2030)
The North America Organ Preservation Market was valued at $68.71 Million in 2025 and projected to reach to $90.06 Million by 2030, representing a compound annual growth rate of 5.6%. North America's organ preservation market is poised for steady growth, driven by increasing organ transplant demand, aging demographics, and technological advancements in preservation systems.
North America Organ Preservation Market Trends and Insights
- This growth in Europe reflects increasing demand for advanced preservation technologies driven by rising organ transplant volumes and regulatory support for innovative medical devices.
- Europe's mature healthcare infrastructure and strong emphasis on transplant outcomes position the region as a key market for organ preservation solutions. The European organ preservation market benefits from stringent quality standards, substantial investment in healthcare innovation, and a growing focus on reducing organ rejection rates.
- Between 2025 and 2030, Europe is expected to see accelerated adoption of machine perfusion systems and improved cold storage solutions.
- Europe's collaborative transplant networks and cross-border organ sharing agreements further support market expansion, as healthcare providers seek technologies that extend organ viability and improve transplant success rates..
Key Market Statistics
- CAGR (2025-2030) 5.6% CAGR
- Market Size, 2025 ~USD 68.71 Million
- Forecast, 2030 ~USD 90.06 Million
- Geography North America
North America Organ Preservation Market Overview
US Market Dominance :
The United States commands the North American organ preservation market with a valuation of $112.99 million in 2025, representing over 94% of the regional market share and driving innovation in preservation technologies.
Strong Healthcare Infrastructure :
North America's advanced healthcare systems, high transplant volumes, and robust regulatory frameworks (FDA, Health Canada) accelerate adoption of cutting-edge organ preservation solutions and cold chain management technologies.
Regional Growth Trajectory :
The North American organ preservation market is projected to expand at a 5.6% CAGR from 2025 to 2030, driven by increasing organ donation rates, aging populations, and rising investment in transplant infrastructure.
Canada's Emerging Contribution :
Canada's organ preservation market is valued at $7.42 million in 2025, with growing demand for preservation technologies supported by national transplant programs and healthcare modernization initiatives.
North America Organ Preservation Market Dynamics
- The region benefits from well-established healthcare infrastructure, strong regulatory support, and significant investment in transplant programs.
- The US market leads with substantial adoption of normothermic and hypothermic preservation technologies, while Canada contributes meaningful growth through national transplant initiatives. Key growth drivers include rising organ donation awareness, improved surgical outcomes, and integration of machine perfusion systems.
- Healthcare providers are increasingly investing in advanced preservation solutions to extend organ viability and reduce transplant failure rates.
- Continued regulatory approvals and reimbursement support will further accelerate market expansion through 2030, positioning North America as a critical hub for organ preservation innovation..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Europe's organ preservation market is valued at $68.71 million in 2025 and projected to reach $90.06 million by 2030, representing a 5.6% CAGR.
- Europe's advanced healthcare infrastructure and regulatory frameworks drive adoption of innovative organ preservation technologies across transplant centers.
- Machine perfusion systems and enhanced cold storage solutions are gaining traction in Europe due to their proven ability to improve organ viability and transplant outcomes.
- Europe's collaborative transplant networks and cross-border organ sharing agreements create sustained demand for reliable preservation solutions through 2030.
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
North America Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Develop and commercialize organ preservation technologies tailored to North American regulatory standards and healthcare provider requirements with market-specific demand forecasts.
- Transplant Centers & Hospitals : Evaluate preservation technology investments, benchmark against regional adoption rates, and optimize procurement strategies based on North American market trends and clinical outcomes.
- Healthcare Investors & PE Firms : Identify investment opportunities in organ preservation companies and transplant infrastructure with detailed North American market sizing, growth projections, and competitive analysis.
- Regulatory & Policy Advisors : Understand market dynamics influencing FDA and Health Canada policy decisions, reimbursement frameworks, and healthcare infrastructure development in organ transplantation.
- Pharmaceutical & Biotech Companies : Assess market opportunities for preservation solutions, perfusion fluids, and adjunctive therapies with North America-specific clinical adoption and commercialization pathways.
Key Companies in the North America Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 112.99 Million |
| Canada | USD 7.42 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Data : Access precise market valuations for the US ($112.99M) and Canada ($7.42M) with 5.6% CAGR projections through 2030, enabling accurate financial forecasting and investment decisions.
- Competitive Landscape Analysis : Understand market dynamics specific to North America, including key players, technology adoption rates, and regional competitive positioning in organ preservation solutions.
- Regulatory & Reimbursement Insights : Gain detailed knowledge of FDA approvals, Health Canada regulations, and insurance reimbursement policies driving market adoption across North American healthcare systems.
- Strategic Market Segmentation : Identify high-growth segments by preservation technology type, organ category, and end-user institution to optimize product development and market entry strategies.
- Regional Growth Drivers : Leverage insights on transplant volume trends, aging population demographics, and healthcare infrastructure investments specific to North America for targeted business expansion.
Frequently asked questions
What is the current size of Europe's organ preservation market?
Europe's organ preservation market is valued at $68.71 million in 2025 and is projected to grow to $90.06 million by 2030.
What is the growth rate for organ preservation in Europe?
Europe's organ preservation market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.
What technologies are driving growth in Europe's organ preservation market?
Machine perfusion systems, advanced cold storage solutions, and real-time organ monitoring technologies are key drivers of growth in Europe's organ preservation market.
How does Europe's regulatory environment support organ preservation innovation?
Europe's stringent quality standards and CE marking requirements encourage development and adoption of advanced organ preservation technologies that meet high safety and efficacy benchmarks.
What role do Europe's transplant networks play in market growth?
Europe's collaborative transplant networks and cross-border organ sharing agreements increase demand for reliable preservation solutions that extend organ viability across international transfers.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report